BACTRIM

This brand name is authorized in United States. It is also authorized in Brazil, Ecuador, Estonia, France, Malta, Mexico, Poland, South Africa, Tunisia, Turkey.

Active ingredients

The drug BACTRIM contains a combination of these active pharmaceutical ingredients (APIs):

1	Sulfamethoxazole UNII JE42381TNV - SULFAMETHOXAZOLE
	Sulfamethoxazole competitively inhibits the utilisation of para-aminobenzoic acid in the synthesis of dihydrofolate by the bacterial cell resulting in bacteriostasis.
	Read more about Sulfamethoxazole
2	Trimethoprim UNII AN164J8Y0X - TRIMETHOPRIM
	Trimethoprim is a dihydrofolate reductase inhibitor, inhibiting the conversion of bacterial dihydrofolic acid to tetrahydrofolic acid, required for the synthesis of some amino acids. Its effects are considerably greater on the cells of micro-organisms than on the mammalian cells.
	Read more about Trimethoprim

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BACTRIM DS Tablet	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01EE01	Sulfamethoxazole and trimethoprim	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01E Sulfonamides and trimethoprim → J01EE Combinations of sulfonamides and trimethoprim, incl. derivatives
Discover more medicines within J01EE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	509020090023517, 509020090023617, 509020090023717, 509020090023817
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	29499-1-11-10, 29526-1-12-10, 6765-MEE-1121, 6812-MEE-1221
EE	Ravimiamet	1008818, 1158948, 1793066, 1816545, 1817580, 1846212, 1853243
FR	Base de données publique des médicaments	64121235, 65181349, 65880598, 69233327
MT	Medicines Authority	AA565/63801
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	145M79, 73349, 73362
PL	Rejestru Produktów Leczniczych	100008671, 100008688, 100008694, 100241568, 100241597, 100241605, 100241657, 100272072, 100274444, 100299585, 100326595, 100327637, 100354500, 100366672, 100391121, 100406450, 100407916, 100463698, 100466850, 100467032
TN	Direction de la Pharmacie et du Médicament	9253081, 9253082, 9253083
TR	İlaç ve Tıbbi Cihaz Kurumu	8699525094636, 8699525094643, 8699525284624, 8699525754615
US	FDA, National Drug Code	49708-145, 49708-146, 80425-0001, 80425-0002, 80425-0003
ZA	Health Products Regulatory Authority	B/20.2/111, F/20.2/191, L/20.2/0064